Passage BIO, Inc.·4

Feb 14, 5:14 PM ET

Fotopoulos Alexandros 4

4 · Passage BIO, Inc. · Filed Feb 14, 2022

Insider Transaction Report

Form 4
Period: 2022-02-10
Fotopoulos Alexandros
Chief Technical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2022-02-10+163,900163,900 total
    Exercise: $4.52Exp: 2032-02-09Common Stock (163,900 underlying)
Holdings
  • Common Stock

    8,383
Footnotes (2)
  • [F1]Includes 2020 Employee Stock Purchase Plan purchases of 1,495 shares that occurred since the date of the Reporting Person's last ownership report.
  • [F2]The stock option vests as to 1/48 of the total shares monthly beginning on March 10, 2022 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Documents

2 files